The emerging role of speckle-type POZ protein (SPOP) in cancer development

Research output: Contribution to journalReview article

40 Scopus citations

Abstract

Speckle-type POZ (pox virus and zinc finger protein) protein (SPOP) is an E3 ubiquitin ligase adaptor protein that is frequently mutated in prostate and endometrial cancers. All the cancer-associated SPOP mutations reported to date are clustered in the meprin and TRAF (Tumor necrosis factor receptor-associated factor) homology (MATH) domain, presumably affecting substrate binding. SPOP mutations in prostate cancer are mutually exclusive with the ETS (Erythroblast transformation-specific) family gene rearrangements and define a distinct molecular subclass of prostate cancer. SPOP mutations contribute to prostate cancer development by altering the steady-state levels of key components in the androgen-signaling pathway.

Original languageEnglish (US)
Pages (from-to)1498-1502
Number of pages5
JournalDrug Discovery Today
Volume19
Issue number9
DOIs
StatePublished - Sep 2014

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'The emerging role of speckle-type POZ protein (SPOP) in cancer development'. Together they form a unique fingerprint.

  • Cite this